All results are NS for efficacy
ST (n=90)
vs.
(n=85)
Sample size: 90/85
Primary endpoint:
FU duration: 21d
(n=752)
placebo (n=0)
double blind
Parallel groups
Sample size: 752/0
Primary endpoint: clinical failure at 6 months after successful PTCA
FU duration: 6 months